AVR vs ZTS · rev $1.9M vs P/E 25, rev $2.47B
Anteris Technologies Global Corp. Common Stock (AVR) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AVR revenue for 2025-12-31 was $1.9M. Net income was -$94.1M. Revenue was down 29.2% from 2024-12-31 to 2025-12-31. AVR currently screens at market cap $287.2M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
AVR currently screens at market cap $287.2M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the AVR and ZTS stock pages for the full models.
Not investment advice.